Weiss Multi-Strategy Advisers LLC - ONCONOVA THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Weiss Multi-Strategy Advisers LLC ownership history of ONCONOVA THERAPEUTICS INC
ValueSharesWeighting
Q1 2016$154,000
-39.4%
265,8720.0%0.01%
-58.8%
Q4 2015$254,000
-22.6%
265,872
+10.4%
0.02%
+21.4%
Q3 2015$328,000
-42.6%
240,8720.0%0.01%
-39.1%
Q2 2015$571,000
-1.7%
240,8720.0%0.02%
-11.5%
Q1 2015$581,000
-0.5%
240,872
+35.6%
0.03%
+30.0%
Q4 2014$584,000
+35.8%
177,658
+77.7%
0.02%
+81.8%
Q3 2014$430,000
-12.4%
100,000
+10.7%
0.01%0.0%
Q2 2014$491,000
-59.1%
90,333
-52.3%
0.01%
-54.2%
Q1 2014$1,201,000
-48.8%
189,400
-7.3%
0.02%
-52.9%
Q4 2013$2,347,000
-40.9%
204,400
+36.3%
0.05%
+18.6%
Q3 2013$3,970,000150,0000.04%
Other shareholders
ONCONOVA THERAPEUTICS INC shareholders Q2 2016
NameSharesValueWeighting ↓
SPHERA FUNDS MANAGEMENT LTD. 120,000$1,378,0000.38%
EMERALD ADVISERS, LLC 367,369$4,217,0000.23%
WEATHERBIE CAPITAL, LLC 176,462$2,026,0000.19%
Catalyst Capital Advisors LLC 25,000$287,0000.09%
Eventide Asset Management 23,000$264,0000.08%
Weiss Multi-Strategy Advisers LLC 204,400$2,347,0000.05%
A.R.T. Advisors, LLC 42,741$490,0000.03%
KINGS POINT CAPITAL MANAGEMENT 5,500$63,0000.02%
SSI INVESTMENT MANAGEMENT LLC 21,470$247,0000.02%
Marshall Wace North America L.P. 14,439$166,0000.00%
View complete list of ONCONOVA THERAPEUTICS INC shareholders